Diligence memo · auto-generated · as of July 2, 2026
Lungpacer Medical, Inc.
Lungpacer Medical, Inc. looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Lungpacer Medical, Inc. operates in Healthtech, based in EXTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Lungpacer Medical, Inc. has raised $121M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $56M on 2019-04-30.
Most recent recorded round closed around 2025-03-18.
Valuation (modeled)modeled
Provath models Lungpacer Medical, Inc. at approximately $70M (range $36M–$96M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.21× the median modeled value of Series C Healthtech companies in 2025–2027 (19 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 16 months.
Last raise 15 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 2.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 96% of Healthtech peers (2138 compared).
Modeled value ranks above 69% of those peers.
Closest niche peers: Thyme Care, Inc., Cohere Health Inc., All Inspire Health, Inc., Harbor Health Team Inc., Apreo Health, Inc..
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.